New technology print custom-dosed medications site

New technology to print custom-dosed medications on site

6:32 AM, 6th October 2017
New technology to print custom-dosed medications on site
Siddharth Suresh Borsadia, materials science & engineering graduate student research assistant, sets up a printing demonstration combining evaporated Fluorescein with Nitrogen which is jetted, much like a 3D printer, onto a variety of cooled surfaces.

ANN ARBOR, US: University of Michigan researchers have developed a new technology that can print pure, ultra-precise doses of drugs onto a wide variety of surfaces could one day enable on-site printing of custom-dosed medications at pharmacies, hospitals and other locations.

The technique can print multiple medications into a single dose on a dissolvable strip, microneedle patch or other dosing devices. The researchers say it could make life easier for patients who must now take multiple medications every day. The work could also accelerate drug development.

A new study led by Max Shtein, professor of materials science and engineering, and Olga Shalev, a recent graduate who worked on the project while a doctoral student in the same department, showed that the pure printed medication can destroy cultured cancer cells in the lab as effectively as medication delivered by traditional means, which rely on chemical solvents to enable the cells to absorb the medication.

Their study is published in the journal Nature Communications.

The technique was developed through a collaboration between the Michigan Engineering departments of Chemical Engineering and Biomedical Engineering, as well as the College of Pharmacy, and the Department of Physics in the College of Literature, Science and the Arts.

The researchers adapted a technology from electronics manufacturing called organic vapour-jet printing. One key advantage of the technique is that it can print a very fine crystalline structure over a large surface area. This helps printed medications dissolve more easily, opening the door to a variety of potential new drugs that today are shelved because they don’t dissolve well when administered with conventional approaches, including pills and capsules.

“Pharma companies have libraries of millions of compounds to evaluate, and one of the first tests is solubility. About half of new compounds fail this test and are ruled out. Organic vapour jet printing could make some of them more soluble, putting them back into the pipeline,” Shtein said.

“Organic vapour jet printing may be useful for a variety of drug delivery applications for the safe and effective delivery of therapeutic agents to target tissues and organs,” said Geeta Mehta, the Dow Corning assistant professor of materials science and engineering and biomedical engineering and a co-author on the paper.

Today, most compounds must be dissolved in a chemical solvent before they’re applied to cells. The new technique could enable printed medications to dissolve easily in the water-based medium used to culture cells, without the need for a solvent.

“When researchers use solvents to dissolve drugs during the testing process, they’re applying those drugs in a way that’s different from how they would be used in people, and that makes the results less useful,” said Anna Schwendeman, an assistant professor of pharmaceutical sciences at U-M and an author on the paper. “Organic vapour jet printing could make those tests much more predictive, not to mention simpler.”

While printing mass-market drugs are likely years away, Shtein believes that the drug characterization and testing applications may come to fruition more quickly; pharma companies could use the machines internally during preliminary testing.

“One of the major challenges facing pharmaceutical companies is speed to clinical testing in humans,” said Gregory Amidon, a research professor in the U-M College of Pharmacy and an author on the paper. “This technology offers up a new approach to accelerate the evaluation of new medicines.”

The team is working on a roadmap for exploring additional applications for the technology and plans to collaborate with experts in pharmaceutical compound design and manufacturing, as well as those working on treatments. Eventually, they envision vapour jet printing being scaled to mass production, including roll-to-roll continuous manufacturing.

The research was supported by the Air Force Office of Scientific Research, the National Science Foundation, and the US Department of Energy Office of Science 

© University of Michigan

0 Comments

Login

Your Comments (Up to 2000 characters)
Please respect our community and the integrity of its participants. WOC reserves the right to moderate and approve your comment.

Related News


AMAI re-elects Anil Kumar as president, Jayantibhai Patel as VP

NEW DELHI, INDIA: Alkali Manufacturers Association of India (AMAI) on its 40th annual general meeting (AGM) said that it has re-elected Anil Kumar, ex ...

Read more
3M completes acquisition of Scott Safety for $2 billion

ST PAUL, US: 3M Company said that it has completed its acquisition of Scott Safety from Johnson Controls for a total enterprise value of $2.0 billion. ...

Read more
Biesterfeld distributes SCIGRIP methyl methacrylate adhesives in Germany

HAMBURG, GERMANY: Biesterfeld Spezialchemie GmbH said that it is distributing two-component methyl methacrylate (MMA) adhesives from SCIGRIP on t ...

Read more
Archroma has listed about 200 substances under REACH

REINACH, SWITZERLAND: Archroma announced a solid progress on phases 3 and 4 of Registration, Evaluation, Authorization and restriction of Chemicals (R ...

Read more
Wacker to increase prices for silicones, pyrogenic silica

MUNICH, GERMANY: Wacker Chemie AG said that it is increasing its prices for silicone polymers, silicone fluids and silicones from downstream productio ...

Read more
New method to produce electricity from tears, saliva, egg whites

LIMERICK, IRELAND: A team of researchers at the University of Limerick has discovered that applying pressure to a protein found in egg whites and tear ...

Read more